Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-20
DOI
10.1038/s41467-019-10592-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization
- (2018) Tanya Schild et al. CANCER CELL
- IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma
- (2018) Bowie Y. Cheng et al. CANCER RESEARCH
- Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment
- (2018) Mark A. Hawk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis
- (2018) Simon-Pierre Gravel Frontiers in Oncology
- An In Vivo Functional Screen Identifies JNK Signaling As a Modulator of Chemotherapeutic Response in Breast Cancer
- (2017) Matthew Ashenden et al. MOLECULAR CANCER THERAPEUTICS
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- Overexpression of Aldo-keto reductase family 1 B10 protein in ductal carcinoma in situ of the breast correlates with HER2 positivity
- (2017) Zezhong Li et al. Cancer Biomarkers
- Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis
- (2016) Camille Lehuédé et al. CANCER RESEARCH
- Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism
- (2016) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Targeting metastasis-initiating cells through the fatty acid receptor CD36
- (2016) Gloria Pascual et al. NATURE
- Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
- (2016) Roman Camarda et al. NATURE MEDICINE
- Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
- (2016) Q Qu et al. Cell Death & Disease
- ROS homeostasis and metabolism: a dangerous liason in cancer cells
- (2016) E Panieri et al. Cell Death & Disease
- Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness
- (2016) Alexandra Avgustinova et al. Nature Communications
- Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
- (2016) Jun Hyoung Park et al. Cell Reports
- Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate
- (2016) Junfei Jin et al. Scientific Reports
- The aldo-keto reductases (AKRs): Overview
- (2015) Trevor M. Penning CHEMICO-BIOLOGICAL INTERACTIONS
- The role of the insulin-like growth factor-1 system in breast cancer
- (2015) Panagiotis F Christopoulos et al. Molecular Cancer
- Oxidative stress inhibits distant metastasis by human melanoma cells
- (2015) Elena Piskounova et al. NATURE
- Antioxidants can increase melanoma metastasis in mice
- (2015) Kristell Le Gal et al. Science Translational Medicine
- PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
- (2014) Valerie S. LeBleu et al. NATURE CELL BIOLOGY
- Antioxidants Accelerate Lung Cancer Progression in Mice
- (2014) V. I. Sayin et al. Science Translational Medicine
- Metabolomics reveals that carnitine palmitoyltransferase-1 is a novel target for oxidative inactivation in human cells
- (2013) Daiki Setoyama et al. GENES TO CELLS
- Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions
- (2013) Kristina A. Matkowskyj et al. HUMAN PATHOLOGY
- Aldo–keto reductases in retinoid metabolism: Search for substrate specificity and inhibitor selectivity
- (2012) Sergio Porté et al. CHEMICO-BIOLOGICAL INTERACTIONS
- AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker
- (2012) Jun Ma et al. INTERNATIONAL JOURNAL OF CANCER
- A metabolic prosurvival role for PML in breast cancer
- (2012) Arkaitz Carracedo et al. JOURNAL OF CLINICAL INVESTIGATION
- Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma
- (2012) Yeon Tae Chung et al. MODERN PATHOLOGY
- Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells
- (2011) Ziwen Liu et al. BIOCHEMICAL JOURNAL
- An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
- (2011) Aikseng Ooi et al. CANCER CELL
- Regulation of aldo–keto reductase AKR1B10 gene expression: Involvement of transcription factor Nrf2
- (2011) Toru Nishinaka et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Human aldo–keto reductases 1B1 and 1B10: A comparative study on their enzyme activity toward electrophilic carbonyl compounds
- (2011) Yi Shen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29
- (2011) Bettina Ebert et al. CHEMICO-BIOLOGICAL INTERACTIONS
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Selective Inhibition of the Tumor Marker AKR1B10 by Antiinflammatory N-Phenylanthranilic Acids and Glycyrrhetic Acid
- (2010) Satoshi Endo et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10
- (2010) Amit Joshi et al. BIOLOGICAL CHEMISTRY
- Aldo–keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels
- (2009) Linlin Zhong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
- (2009) Zachary T. Schafer et al. NATURE
- Role of human aldo–keto-reductase AKR1B10 in the protection against toxic aldehydes
- (2008) Hans-Jörg Martin et al. CHEMICO-BIOLOGICAL INTERACTIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started